GenVec's IPO

GenVec raised a round of funding on December 12, 2000. Investors include Public.

GenVec (NASDAQ: GNVC) is a clinical-stage biopharmaceutical company and pioneer in the development of AdenoVerse gene delivery technology platform.…

Articles about GenVec's IPO: